Literature DB >> 12407130

Characterization of a laboratory-generated variant of BPS beta-lactamase from Burkholderia pseudomallei that hydrolyses ceftazidime.

P L Ho1, Terence K M Cheung, W C Yam, K Y Yuen.   

Abstract

Burkholderia pseudomallei produces an Ambler class A beta-lactamase, known as BPS-1. The beta-lactamase gene from a laboratory-derived, ceftazidime-resistant strain of B. pseudomallei (LH-1-2) was cloned and expressed in Escherichia coli. The beta-lactamase, named BPS-1m, had an identical isoelectric focusing point (pI 7.7) to that of BPS-1, but differed in having a stronger hydrolytic activity against ceftazidime. Susceptibility testing showed that BPS-1m when expressed in E. coli conferred resistance to ceftazidime (MIC >or= 32 mg/L). The amino acid sequence of BPS-1m differed from that of BPS-1 by a Pro-to-Ser change at position 167 in the omega loop.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12407130     DOI: 10.1093/jac/dkf208

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  15 in total

Review 1.  Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes.

Authors:  R Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

Review 2.  A Structure-Based Classification of Class A β-Lactamases, a Broadly Diverse Family of Enzymes.

Authors:  Alain Philippon; Patrick Slama; Paul Dény; Roger Labia
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

3.  Unexpected enzyme TEM-126: role of mutation Asp179Glu.

Authors:  J Delmas; F Robin; F Bittar; C Chanal; R Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

4.  Functional characterization of OXA-57, a class D beta-lactamase from Burkholderia pseudomallei.

Authors:  Karen E Keith; Petra C Oyston; Ben Crossett; Neil F Fairweather; Richard W Titball; Timothy R Walsh; Katherine A Brown
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

5.  Prediction of the evolution of ceftazidime resistance in extended-spectrum beta-lactamase CTX-M-9.

Authors:  J Delmas; F Robin; F Carvalho; C Mongaret; R Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

6.  Deletion mutations conferring substrate spectrum extension in the class A β-lactamase.

Authors:  Junghyun Hwang; Kwang-Hwi Cho; Han Song; Hyojeong Yi; Heenam Stanley Kim
Journal:  Antimicrob Agents Chemother       Date:  2014-07-21       Impact factor: 5.191

Review 7.  Mechanisms of antibiotic resistance in Burkholderia pseudomallei: implications for treatment of melioidosis.

Authors:  Herbert P Schweizer
Journal:  Future Microbiol       Date:  2012-12       Impact factor: 3.165

8.  Antimicrobial resistance to ceftazidime involving loss of penicillin-binding protein 3 in Burkholderia pseudomallei.

Authors:  Narisara Chantratita; Drew A Rholl; Bernice Sim; Vanaporn Wuthiekanun; Direk Limmathurotsakul; Premjit Amornchai; Aunchalee Thanwisai; Hui Hoon Chua; Wen Fong Ooi; Matthew T G Holden; Nicholas P Day; Patrick Tan; Herbert P Schweizer; Sharon J Peacock
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-03       Impact factor: 11.205

9.  Variations in ceftazidime and amoxicillin-clavulanate susceptibilities within a clonal infection of Burkholderia pseudomallei.

Authors:  I-Ching Sam; Kah Heng See; Savithri D Puthucheary
Journal:  J Clin Microbiol       Date:  2009-03-18       Impact factor: 5.948

10.  Role of a mutation at position 167 of CTX-M-19 in ceftazidime hydrolysis.

Authors:  Soichiro Kimura; Masaji Ishiguro; Yoshikazu Ishii; Jimena Alba; Keizo Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.